Financhill
Back

Regenxbio Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
30

RGNX
Regenxbio

Last Price:
9.24
Seasonality Move:
0.61%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Regenxbio Price Quote

$9.24
+0.32 (+3.59%)
(Updated: November 6, 2024 at 10:20 AM ET)

Regenxbio Key Stats

Sell
30
Regenxbio (RGNX) is a Sell

Day range:
$8.58 - $8.97
52-week range:
$8.54 - $28.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.62
P/B ratio:
1.27%

Volume:
364.2K
Avg. volume:
492K
1-year change:
-41.81%
Market cap:
$440.9M
Revenue:
$90.2M
EPS:
$-5.26

How Much Does Regenxbio Make?

  • How Much Are Regenxbio's Sales Annually?
    RGNX Revenues are $90.2M
  • How Much Profit Does Regenxbio's Make A Year?
    RGNX net income is -$263.5M

Is Regenxbio Growing As A Company?

  • What Is Regenxbio's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.12%
  • What Is Regenxbio's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Regenxbio Stock Price Performance

  • Did Regenxbio Stock Go Up Last Month?
    Regenxbio share price went down by -8.23% last month
  • Did RGNX's Share Price Rise Over The Last Year?
    RGNX share price fell by -41.81% over the past 1 year

What Is Regenxbio 52-Week High & Low?

  • What Is Regenxbio’s 52-Week High Share Price?
    Regenxbio has traded as high as $28.80 over the past 52 weeks
  • What Is Regenxbio’s 52-Week Low Share Price?
    Regenxbio has traded as low as $8.54 over the past 52 weeks

Regenxbio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Regenxbio?

  • How Much Debt Does Regenxbio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Regenxbio Have?
    Cash and short term investments quarterly total is $290.4M
  • What Is Regenxbio’s Book Value Per Share?
    Book value per share is 7.06

Is Regenxbio Cash Flow Positive?

  • What Is RGNX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$191.1M
  • What Is Regenxbio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $94.5M
  • What Is Regenxbio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $85.5M

Regenxbio Return On Invested Capital

  • Is Management Doing A Good Job?
    RGNX return on invested capital is -66.24%
  • What Is Regenxbio Return On Assets?
    ROA measures how assets are converting to revenues and is -39.02%
  • What Is RGNX Return On Equity?
    ROE is a measure of profitability and is -66.24%

Regenxbio Earnings Date & Stock Price

  • What Is Regenxbio's Stock Price Today?
    A single share of RGNX can be purchased today for 8.92
  • What Is Regenxbio’s Stock Symbol?
    Regenxbio trades on the nasdaq under the ticker symbol: RGNX
  • When Is Regenxbio’s Next Earnings Date?
    The next quarterly earnings date for Regenxbio is scheduled on November 6, 2024
  • When Is RGNX's next ex-dividend date?
    Regenxbio's next ex-dividend date is November 6, 2024
  • How To Buy Regenxbio Stock?
    You can buy Regenxbio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Regenxbio Competitors

  • Who Are Regenxbio's Competitors?
    Below is a list of companies who compete with Regenxbio or are related in some way:
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Edgewise Therapeutics Inc (EWTX)
    • Sarepta Therapeutics Inc (SRPT)
    • Entrada Therapeutics Inc (TRDA)
    • Vertex Pharmaceuticals Inc (VRTX)

Regenxbio Dividend Yield

  • What Is RGNX Dividend Yield?
    Regenxbio’s dividend yield currently is 0%
  • What Is Regenxbio’s Payout Ratio?
    Regenxbio’s payout ratio is 0%
  • When Did Regenxbio Last Pay A Dividend?
    The latest dividend pay date is November 6, 2024
  • What Is Regenxbio’s Dividend Per Share?
    Regenxbio pays a dividend of $0.00 per share

Regenxbio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20.12%
Revenue: 11.6% -2.95%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 36.54
Upside from Last Price: 309.62%

Major Shareholders

  • How many RGNX shares are owned by institutional investors?
    63.2M RGNX shares are owned by institutional investors
  • How many RGNX shares are owned by insiders?
    1.5M RGNX shares are owned by insiders